CAPEK JOHN M 4
4 · ABBOTT LABORATORIES · Filed Aug 31, 2020
Insider Transaction Report
Form 4
CAPEK JOHN M
Executive Vice President
Transactions
- Exercise/Conversion
Option (right to buy)
2020-08-27−52,300→ 0 totalExercise: $27.03From: 2015-02-17Exp: 2022-02-16→ Common shares (52,300 underlying) - Exercise/Conversion
Common shares without par value
2020-08-27$27.03/sh+52,300$1,413,857→ 369,100 total - Sale
Common shares without par value
2020-08-27$111.86/sh−52,300$5,850,278→ 316,800 total
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.